Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 230

The DOI matches its Crossref record.

Biological Effects of Estradiol-17β in Postmenopausal Women: Oral Versus percutaneous Administration

LIGNIERS, BRUNO DE, BASDEVANT, ARNAUD, THOMAS, GUY, THALABARD, JEAN-CHRISTOPHE, MERCIER-BODARD, CHRISTINE, CONARD, JACQUELINE, GUYENE, THANH-TAM, MAIRON, NICOLE, CORVOL, PIERRE, GUY-GRAND, BERNARD, MAUVAIS-JARVIS, PIERRE, SITRUK-WARE, REGINE·1986·The Journal of Clinical Endocrinology & Metabolism

Abstract

To determine whether the route of administration or the type of estrogen used in estrogen replacement therapy (ERT) is more important in avoiding effects on hepatic function, 24 postmenopausal women were studied before and at the end of 2 months of oral or percutaneous administration of the same estrogen, estradiol-17 beta (E2). The treatments studied were oral micronized E2, 2 mg/day (9 women); oral E2 valerate, 2 mg/day (5 women), and percutaneous E2, 3 mg/day (10 women). Specific plasma biological and biochemical markers of estrogenic action were evaluated, namely, E2, estrone (E1), LH, FSH, sex steroid binding protein (SBP), renin substrate, antithrombin activity, and lipoproteins (high density lipoprotein cholesterol, low density lipoprotein cholesterol, very low density lipoprotein triglycerides). Both oral and percutaneous administration of E2 increased plasma E2 levels up to midfollicular values and decreased LH and FSH levels into the same range. Oral administration of E2 led to substantial increases in plasma E1, SBP, renin substrate, and VLDL levels, whereas AT decreased significantly. Percutaneous administration of E2 led to a physiological plasma E1/E2 ratio and did not induce any change in hepatic proteins. These data suggest that the route of administration of E2 determines the biochemical response to ERT in postmenopausal women. SBP is the most sensitive marker of the liver action of estrogen, and triglycerides also are simple and useful markers for this effect. Percutaneous E2 therapy is an effective method of ERT, and has no measurable effects on hepatic markers of estrogen action.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jcem-62-3-536

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 230

Metadata

Authors
LIGNIERS, B. D., BASDEVANT, A., THOMAS, G., THALABARD, J.-C., MERCIER-BODARD, C., CONARD, J., GUYENE, T.-T., MAIRON, N., CORVOL, P., GUY-GRAND, B., MAUVAIS-JARVIS, P., & SITRUK-WARE, R.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
1986-03
Volume
62
Issue
3
Pages
536-541
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W1978092733
Cited by
230
References
0
FWCI
7.50
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Biological Effects of Estradiol-17β in Postmenopausal Women: Oral Versus percutaneous Administration. https://app.cochat.ai/papers/10.1210/jcem-62-3-536
The paper
LIGNIERS, B. D., BASDEVANT, A., THOMAS, G., THALABARD, J.-C., MERCIER-BODARD, C., CONARD, J., GUYENE, T.-T., MAIRON, N., CORVOL, P., GUY-GRAND, B., MAUVAIS-JARVIS, P., & SITRUK-WARE, R. (1986). Biological Effects of Estradiol-17β in Postmenopausal Women: Oral Versus percutaneous Administration. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jcem-62-3-536

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.